全国服务咨询热线:
18501609238
18501609238
AOA体育相关的文章
Related Articles详细介绍
| 品牌 | 其他品牌 | 供货周期 | 现货 |
|---|---|---|---|
| 应用领域 | 医疗卫生,环保,食品,化工,生物产业 |
Biovisoin代理销售 1663-1
Biovisoin代理销售 1663-1
| 1663-1 | IQ-1 |
| 1666-5 | PD 98059 |
| 1667-25 | LY 294002 |
| 1667-5 | LY 294002 |
| 1668-5 | U0126 |
| 1669-5 | SP600125 |
| 1670-1 | Wortmannin, Penicillium funiculosum |
| 1671-10 | Tetrahydrouridine |
| 1671-25 | Tetrahydrouridine |
| 1672-5 | Purmorphamine |
| 1673-1 | BIO |
| 1674-1 | SB-431542 |
| 1674-5 | SB-431542 |
| 1675-1 | PD 173074 |
| 1676-100 | PDTC |
| 1677-25 | CHIR 99021 |
| 1677-5 | CHIR 99021 |
| 1678-25 | BIX 01294 |
| 1678-5 | BIX 01294 |
| 1679-10 | RG 108 |
| 1679-30 | RG 108 |
| 1680-5 | QS11 |
| 1681-1 | Thiazovivin |
| 1681-5 | Thiazovivin |
| 1682-5 | (+-)-Bay K 8644 |
| 1683-5 | NVP-TAE684 |
| 1685-5 | ATM Kinase Inhibitor, KU-55933 |
| 1686-5 | Dorsomorphin |
| 1687-50 | AICAR |
| 1687-250 | AICAR |
| 1688-5 | Compound 1 |
| 1689-05 | Jasplakinolide, jaspis johnstoni |
| 1690-200 | Butyrolactone I |
| 1691-5G | Metformin, Hydrochloride |
| 1692-250 | Lovastatin |
| 1692-50 | Lovastatin |
| 1693-250 | Simvastatin |
| 1693-50 | Simvastatin |
| 1694-250 | Mevastatin |
| 1694-50 | Mevastatin |
| 1695-5 | Ciglitazone |
| 1696-5 | Troglitazone |
| 1697-5 | GW 9662 |
| 1698-100 | Imiquimod |
| 1698-500 | Imiquimod |
| 1699-5 | Resiquimod |
| 1699-25 | Resiquimod |
| 1700-100 | Pam3Cys-Ser-(Lys)4, Trihydrochloride |
| 1702-1 | Chk2 Inhibitor |
| 1703-5 | MG-132 |
| 1703-25 | MG-132 |
| 1704-1 | Batimastat (MMP Inhibitor) |
| 1704-5 | Batimastat (MMP Inhibitor) |
| 1705-500 | Obestatin (Human) |
| 1707-1 | Triciribine |
| 1708-1 | Akt Inhibitor, Isozyme-Selective |
| 1709-200 | Lactacystin (Synthetic) |
| 1710-100 | Clasto-Lactacystin β-lactone |
| 1711-500 | Gö 6976 |
| 1712-1 | SB 203580 |
| 1712-5 | SB 203580 |
| 1713-250 | L-685, 458 |
| 1714-100 | IBMX |
| 1715-25 | Zaprinast |
| 1716-1 | SCD1 Inhibitor |
| 1716-5 | SCD1 Inhibitor |
| 1717-1 | ACC2 Inhibitor |
| 1719-5 | A-769662 |
| 1722-5 | TGR5 Receptor Agonist |
| 1724-1 | Tubastatin A |
| 1724-5 | Tubastatin A |
| 1725-1 | A 83-01 |
| 1726-1 | JK 184 |
| 1727-1 | XAV939 |
| 1728-1 | PI-103 |
| 1728-5 | PI-103 |
| 1729-1 | Pyrintegrin |
| 1729-5 | Pyrintegrin |
| 1730-25 | Oridonin |
| 1730-5 | Oridonin |
| 1731-100 | Oleanolic Acid |
| 1731-500 | Oleanolic Acid |
| 1732-25 | Pepstatin A |
| 1732-100 | Pepstatin A |
| 1733-25 | Bestatin |
| 1733-100 | Bestatin |
| 1736-1 | EZSolution™ Thiazovivin |
| 1737-1 | EZSolution™ Pyrintegrin |
| 1738-5G | ASB-14 |
| 1738-25G | ASB-14 |
| 1739-5 | E-64 |
| 1739-25 | E-64 |
| 1740-5 | GW2580 |
| 1740-25 | GW2580 |
| 1741-100 | Capecitabine |
| 1741-1000 | Capecitabine |
| 1742-10 | CI-994 |
| 1742-50 | CI-994 |
| 1743-500 | Stauprimide |
| 1745-01 | EZSolution™ Staurosporine |
| 1746-5 | EZSolution™ Rapamycin |
| 1747-5 | EZSolution™ LY294002 |
| 1748-5 | EZSolution™ CHIR99021 |
| 1749-100 | Catharanthine |
| 1749-1000 | Catharanthine |
| 1750-25 | Nilotinib |
| 1750-100 | Nilotinib |
| 1751-25 | Vandetanib |
| 1751-100 | Vandetanib |
| 1752-50 | Irinotecan Hydrochloride |
| 1752-250 | Irinotecan Hydrochloride |
| 1753-5 | Epirubicin Hydrochloride |
| 1753-25 | Epirubicin Hydrochloride |
| 1754-10 | 5-Aza-2'-deoxycytidine |
| 1754-50 | 5-Aza-2'-deoxycytidine |
| 1755-50 | Calcein AM |
| 1755-250 | Calcein AM |
| 1756-100 | Teicoplanin |
| 1756-1G | Teicoplanin |
| 1757-100 | Sitagliptin Phosphate Monohydrate |
| 1757-1G | Sitagliptin Phosphate Monohydrate |
| 1758-100 | Resveratrol |
| 1758-500 | Resveratrol |
| 1759-25 | Gemcitabine Hydrochloride |
| 1759-100 | Gemcitabine Hydrochloride |
| 1760-10 | Nafamostat Mesylate |
| 1760-50 | Nafamostat Mesylate |
| 1761-1 | Triptolide |
| 1761-5 | Triptolide |
| 1762-10 | Honokiol |
| 1762-50 | Honokiol |
| 1763-10 | Fludarabine Phosphate |
| 1763-50 | Fludarabine Phosphate |
| 1764-025 | Okadaic acid, Sodium Salt |
| 1764-100 | Okadaic acid, Sodium Salt |
| 1765-025 | Okadaic acid, Potassium Salt |
| 1765-100 | Okadaic acid, Potassium Salt |
| 1766-025 | Okadaic acid, Ammonium Salt |
| 1766-100 | Okadaic acid, Ammonium Salt |
| 1767-1 | PP2 |
| 1767-5 | PP2 |
| 1768-1 | H-89 Dihydrochloride |
| 1768-5 | H-89 Dihydrochloride |
| 1769-1 | SB 216763 |
| 1769-5 | SB 216763 |
| 1770-1 | D4476 |
| 1770-5 | D4476 |
| 1771-1 | DR2313 |
| 1771-5 | DR2313 |
| 1772-250 | Naringenin |
| 1772-1000 | Naringenin |
| 1773-250 | Quercetin, Dihydrate |
| 1773-1000 | Quercetin, Dihydrate |
| 1774-1 | 17-AAG |
| 1774-5 | 17-AAG |
| 1775-5 | Stat3 Inhibitor I, S3I-201 |
| 1775-25 | Stat3 Inhibitor I, S3I-201 |
| 1776-1 | 17-DMAG hydrochloride |
| 1776-5 | 17-DMAG hydrochloride |
| 1777-5G | Sulfobetaine 3-16 |
| 1777-25G | Sulfobetaine 3-16 |
| 1778-1 | Stat3 Peptide Inhibitor, Cell-Permeable |
| 1778-5 | Stat3 Peptide Inhibitor, Cell-Permeable |
| 1779-1 | mTOR Inhibitor, Ku-0063794 |
| 1779-5 | mTOR Inhibitor, Ku-0063794 |
| 1780-1 | PI3-Kɣ Inhibitor, AS-605240 |
| 1780-5 | PI3-Kɣ Inhibitor, AS-605240 |
| 1781-1 | TGX-221 |
| 1781-5 | TGX-221 |
| 1782-1G | Octyl-β-D-thioglucopyranoside |
| 1782-5G | Octyl-β-D-thioglucopyranoside |
| 1782-50G | Octyl-β-D-thioglucopyranoside |
| 1782-100G | Octyl-β-D-thioglucopyranoside |
| 1783-5 | EZSolution™ PD 98059 |
| 1784-5 | EZSolution™ Y-27632 |
| 1785-500 | EZSolution™ Gö 6976 |
| 1786-1 | EZSolution™ SB 203580 |
| 1787-10 | Fasudil, Monohydrochloride |
| 1787-50 | Fasudil, Monohydrochloride |
| 1789-1 | ZM 336372 |
| 1789-5 | ZM 336372 |
| 1790-1 | Marimastat |
| 1790-5 | Marimastat |
| 1791-5 | EZSolution™ MG-132 |
| 1792-5 | LLL12 |
| 1792-25 | LLL12 |
| 1793-5 | bpV(phen) |
| 1794-5 | bpV(pic) |
| 1796-1 | Bay 61-3606 Hydrochloride |
| 1796-5 | Bay 61-3606 Hydrochloride |
| 1797-10 | PP3 |
| 1797-50 | PP3 |
| 1798-100 | 2-APB |
| 1799-1 | GM 6001 |
| 1800-5 | AG 1478 |
| 1800-25 | AG 1478 |
| 1801-5 | VO-OHpic, Trihydrate |
| 1801-25 | VO-OHpic, Trihydrate |
| 1802-25G | Imidazole, MegaPure™ |
| 1802-100G | Imidazole, MegaPure™ |
| 1803-25 | EZSolution™ Tozasertib |
| 1804-25 | EZSolution™ Sunitinib Malate |
| 1805-500 | Lestaurtinib |
| 1805-1000 | Lestaurtinib |
| 1808-50 | Monensin Methyl Ester |
| 1808-250 | Monensin Methyl Ester |
| 1809-5 | WP1066 |
| 1809-25 | WP1066 |
| 1811-1 | IKK-ε Kinase Inhibitor II |
| 1811-5 | IKK-ε Kinase Inhibitor II |
| 1812-5 | GANT58 |
| 1812-25 | GANT58 |
| 1813-2 | Stat3 Activation Inhibitor, SPI |
| 1814-025 | Leptomycin B |
| 1815-5 | CP-31398 Dihydrochloride |
| 1815-25 | CP-31398 Dihydrochloride |
| 1816-25 | Tranylcypromine Hemisulfate |
| 1816-100 | Tranylcypromine Hemisulfate |
| 1817-100 | IPAM |
| 1817-500 | IPAM |
| 1817-1000 | IPAM |
| 1818-500 | SH-5 |
| 1819-500 | SH-6 |
| 1820-100 | Bongkrekic Acid, Triammonium Salt |
| 1821-5 | Heparin-Binding Peptide I |
| 1821-25 | Heparin-Binding Peptide I |
| 1822-5 | Heparin-Binding Peptide II |
| 1822-25 | Heparin-Binding Peptide II |
| 1823-5 | Heparin-Binding Peptide III |
| 1823-25 | Heparin-Binding Peptide III |
| 1824-5 | Integrin Ligand peptide |
| 1824-25 | Integrin Ligand peptide |
| 1825-100 | Chloroquine Diphosphate |
| 1825-500 | Chloroquine Diphosphate |
| 1826-100 | Niclosamide |
| 1826-500 | Niclosamide |
| 1827-10 | Rottlerin |
| 1828-100 | Amiodarone Hydrochloride |
| 1828-500 | Amiodarone Hydrochloride |
| 1829-50 | Bafilomycin A1 |
| 1829-250 | Bafilomycin A1 |
| 1830-100 | Berberine Chloride |
| 1830-500 | Berberine Chloride |
| 1831-1 | MG-115 |
| 1831-5 | MG-115 |
| 1832-1 | Proteasome Substrate, Fluorogenic |
| 1832-5 | Proteasome Substrate, Fluorogenic |
| 1833-5 | Suc-Leu-Leu-Val-Tyr-AMC |
| 1833-25 | Suc-Leu-Leu-Val-Tyr-AMC |
| 1834-5 | Calpain Inhibitor I, ALLN |
| 1834-25 | Calpain Inhibitor I, ALLN |
| 1835-5 | Calpain Inhibitor II, ALLM |
| 1835-25 | Calpain Inhibitor II, ALLM |
| 1836-1 | SU 1498 |
| 1836-5 | SU 1498 |
| 1837-5 | 8-Br-cAMP |
| 1837-25 | 8-Br-cAMP |
| 1838-5 | 8-Br-cGMP |
| 1838-25 | 8-Br-cGMP |
| 1840-100 | Microcystin-LR |
| 1840-500 | Microcystin-LR |
| 1841-50 | (-)-Epigallocatechin gallate |
| 1842-1 | Nutlin-3 |
| 1842-5 | Nutlin-3 |
| 1843-50 | Rosmarinic Acid |
| 1843-250 | Rosmarinic Acid |
| 1844-25 | 7-Amino-4-methylcoumarin |
| 1844-100 | 7-Amino-4-methylcoumarin |
| 1845-5 | USP14 Inhibitor, IU1 |
| 1845-25 | USP14 Inhibitor, IU1 |
| 1846-1 | PS-341 |
| 1846-5 | PS-341 |
| 1847-5 | GGACK Dihydrochloride |
| 1848-5 | PPACK Dihydrochloride |
| 1849-5 | Anacardic Acid |
| 1849-25 | Anacardic Acid |
| 1850-10 | Curcumin, Curcuma longa (High Purity) |
| 1850-50 | Curcumin, Curcuma longa (High Purity) |
| 1851-1 | Reversine |
| 1851-5 | Reversine |
| 1852-5 | MoTP |
| 1852-25 | MoTP |
| 1853-5 | WHI-P131 |
| 1853-25 | WHI-P131 |
| 1854-50 | 5-Azacytidine |
| 1854-250 | 5-Azacytidine |
| 1855-5 | DAPT |
| 1856-5 | SMER28 |
| 1856-25 | SMER28 |
| 1857-5 | SIRT2 Inhibitor |
| 1857-25 | SIRT2 Inhibitor |
| 1858-5 | DBeQ |
| 1858-25 | DBeQ |
| 1859-25 | Blasticidin S Hydrochloride |
| 1859-100 | Blasticidin S Hydrochloride |
| 1860-25 | Puromycin Dihydrochloride |
| 1860-100 | Puromycin Dihydrochloride |
| 1860-250 | Puromycin Dihydrochloride |
| 1860-500 | Puromycin Dihydrochloride |
| 1860-1000 | Puromycin Dihydrochloride |
| 1861-100 | EZSolution™ Puromycin Dihydrochloride |
| 1862-25 | (R,S)-Lenalidomide |
| 1862-100 | (R,S)-Lenalidomide |
| 1863-100 | Rocaglamide |
| 1864-5 | Necrostatin-1 |
| 1864-25 | Necrostatin-1 |
| 1865-5 | Necrostatin-5 |
| 1865-25 | Necrostatin-5 |
| 1866-5 | Necrostatin-7 |
| 1866-25 | Necrostatin-7 |
| 1867-10 | BAY 11-7082 |
| 1867-50 | BAY 11-7082 |
| 1868-10 | Parthenolide |
| 1868-50 | Parthenolide |
| 1869-5 | PS48 |
| 1869-25 | PS48 |
| 1869-100 | PS48 |
| 1870-10 | SC66 |
| 1870-50 | SC66 |
| 1871-1 | EZSolution™ PD184352 |
| 1872-1 | EZSolution™ SB-431542 |
| 1873-5 | Salermide |
| 1873-25 | Salermide |
| 1874-50 | Suramin Hexasodium Salt |
| 1874-250 | Suramin Hexasodium Salt |
| 1875-25 | Emodin |
| 1875-100 | Emodin |
| 1876-10 | Tranilast |
| 1876-50 | Tranilast |
| 1877-5 | Pioglitazone |
| 1877-25 | Pioglitazone |
| 1877-100 | Pioglitazone |
| 1878-500 | Glibenclamide |
| 1878-1000 | Glibenclamide |
| 1879-1 | Tiliroside |
| 1879-5 | Tiliroside |
| 1880-50 | Calcitriol |
| 1880-250 | Calcitriol |
| 1882-50 | Mycophenolic Acid |
| 1882-250 | Mycophenolic Acid |
| 1883-500 | Deferoxamine Mesylate |
| 1883-1000 | Deferoxamine Mesylate |
| 1884-50 | Pamidronate disodium |
| 1884-250 | Pamidronate disodium |
| 1885-50 | Mitoxantrone |
| 1885-250 | Mitoxantrone |
| 1886-25 | 7,3',4'-Trihydroxyisoflavone |
| 1886-100 | 7,3',4'-Trihydroxyisoflavone |
| 1887-50 | Pimozide |
| 1887-250 | Pimozide |
| 1888-500 | MK-2206 |
| 1888-1000 | MK-2206 |
| 1889-100 | Phenformin hydrochloride |
| 1889-1000 | Phenformin hydrochloride |
| 1890-5 | GDC-0449 |
| 1890-25 | GDC-0449 |
| 1891-5 | Nimbolide |
| 1891-25 | Nimbolide |
| 1892-5 | GANT61 |
| 1893-25 | Tomatidine hydrochloride |
| 1894-5 | RepSox |
| 1894-25 | RepSox |
| 1895-5 | MIF-Antagonist, ISO-1 |
| 1896-5 | CRT Inhibitor, iCRT5 |
| 1896-25 | CRT Inhibitor, iCRT5 |
| 1897-1 | Alsterpaullone |
| 1897-5 | Alsterpaullone |
| 1898-200 | Compound 34 |
| 1898-1000 | Compound 34 |
| 1899-1 | DPQ |
| 1899-5 | DPQ |
| 1900-5 | Dynasore |
| 1900-25 | Dynasore |
| 1902-5 | SR1001 |
| 1902-25 | SR1001 |
| 1903-5 | Neuropathiazol |
| 1903-25 | Neuropathiazol |
| 1904-1 | Kenpaullone |
| 1905-5 | TG003 |
| 1905-25 | TG003 |
| 1906-5 | PD 150,606 |
| 1906-25 | PD 150,606 |
| 1907-5 | NSC 146109 hydrochloride |
| 1908-5 | GYY 4137 |
| 1908-25 | GYY 4137 |
| 1909-1 | KN-93, Water-Soluble |
| 1909-5 | KN-93, Water-Soluble |
| 1910-50 | Cyclopamine-KAAD |
| 1911-1 | MS-1020 |
| 1912-5 | Ro 61-8048 |
| 1912-25 | Ro 61-8048 |
| 1913-5 | JM6 |
| 1913-25 | JM6 |
| 1914-1 | FK-866 |
| 1914-5 | FK-866 |
| 1915-1 | Shz-1 |
| 1915-5 | Shz-1 |
| 1916-5 | GW-786034 |
| 1916-25 | GW-786034 |
| 1917-5 | Everolimus |
| 1917-25 | Everolimus |
| 1918-50 | Ganciclovir |
| 1918-250 | Ganciclovir |
| 1918-1000 | Ganciclovir |
| 1919-10 | Piperlongumine |
| 1919-50 | Piperlongumine |
| 1920-5 | Tenofovir disoproxil fumarate |
| 1920-25 | Tenofovir disoproxil fumarate |
| 1921-5 | Elastase Inhibitor, SPCK |
| 1922-5 | Elastase Inhibitor |
| 1923-1 | Robotnikinin |
| 1924-1 | BI-D1870 |
| 1924-5 | BI-D1870 |
| 1925-5 | PYR-41 |
| 1925-25 | PYR-41 |
| 1926-5 | Cardiogenol C hydrochloride |
| 1926-25 | Cardiogenol C hydrochloride |
| 1927-1 | PP1 |
| 1927-5 | PP1 |
| 1928-5 | FAAH Inhibitor, PF-622 |
| 1928-25 | FAAH Inhibitor, PF-622 |
| 1929-5 | MLS-573151 |
| 1929-25 | MLS-573151 |
| 1930-100 | Streptozocin |
| 1930-500 | Streptozocin |
| 1930-1000 | Streptozocin |
| 1931-5 | SU 6668 |
| 1931-25 | SU 6668 |
| 1933-1 | UNC0638 |
| 1933-5 | UNC0638 |
| 1934-5 | Crizotinib |
| 1934-25 | Crizotinib |
| 1935-5 | Carbozantinib |
| 1935-25 | Carbozantinib |
| 1936-1 | Fostamatinib Disodium |
| 1936-5 | Fostamatinib Disodium |
| 1938-5 | SU 11274 |
| 1938-25 | SU 11274 |
| 1939-500 | Smo Agonist, SAG |
| 1939-1000 | Smo Agonist, SAG |
| 1940-5 | Celastrol |
| 1940-25 | Celastrol |
| 1941-1 | NSC 23766 |
| 1941-5 | NSC 23766 |
| 1942-5 | Betulin |
| 1942-25 | Betulin |
| 1943-5 | AMI-1 |
| 1943-25 | AMI-1 |
| 1944-1 | 1-Azakenpaullone |
| 1944-5 | 1-Azakenpaullone |
产品咨询
电话
微信扫一扫
当前位置：
地址：上海市奉贤区金大公路8218号1幢
邮箱：yihbio@163.com
传真：021-62962298